Pharmaceutical Supply – DIPHENHYDRAMINE HYDROCHLORIDE INJECTION

The contract mandates the supply and delivery of 4,000 boxes of DIPHENHYDRAMINE HYDROCHLORIDE INJECTION at a rate of $43.38 per unit, fulfilling a critical pharmaceutical requirement under the Defense Logistics Agency’s medical supply program. This is a subcontract under a broader DLA framework, ensuring consistent availability of this essential injectable medication for military and defense medical operations. The product is classified under NAICS code 325412, indicating it falls within pharmaceutical manufacturing, and the delivery terms are linked to the contract and delivery identifiers SPE2DX25D9822 and SPE2D226F3214, confirming its integration into the Defense Industrial Base Boot System. All performance and fulfillment obligations are governed by the Defense Logistics Agency, a component of the Department of Defense, with no specific set-aside provisions or geographic restrictions outlined. The solicitation was posted on August 7, 2026, and while no point of contact or physical delivery location is provided, the contract is active within DLA’s automated procurement ecosystem, requiring strict adherence to federal pharmaceutical standards and timelines. The volume and pricing structure reflect a standardized procurement approach aimed at maintaining inventory readiness across defense medical facilities.